{"id":"c1b63651-6424-4490-8b22-296da7acc1c4","kind":"institutions","code":"UB-I5493","name":"Saimofei","nameBasis":"transliterated","summary":"Saimofei is a Chinese venture capital firm, investing primarily in early- to growth-stage technology companies.","description":"Saimofei is a Chinese venture capital firm, investing primarily in early- to growth-stage technology companies.","country":null,"category":null,"originalName":"赛默飞","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:30.525Z","englishUpdatedAt":"2026-10-15T18:26:25.115Z","reviewedAt":"2026-10-15T18:26:25.115Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"f3dad43b23fb17595981da5749569b34d42b855b9ab40a1ad7864e75edeefd30","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"中国的风险投资机构赛默飞，重点投向早期到成长期科技企业。","sources":[],"related":[{"id":"d537c012-b7aa-4228-969b-b31e8ef7c43d","kind":"news","code":"d537c012-b7aa-4228-969b-b31e8ef7c43d","name":"cytoReason raises USD 80 million in strategic financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"cytoReason完成8000万美元战略投资融资","eventDate":"2024-07-18T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T11:38:13.219Z","englishUpdatedAt":"2026-10-15T17:20:00.058Z","reviewedAt":"2026-10-15T17:20:00.058Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"5eab5a1aa9aa0ec81ef053a5c3c43a64a2261db7adec1d7b0f6ccb91c732b2ac","companyId":"5d107c78-a2e8-409e-9b53-5aa8d34c431a","foundedYear":null,"logoUrl":null,"path":"/news/d537c012-b7aa-4228-969b-b31e8ef7c43d"}],"path":"/institutions/saimofei","canonical":"https://uniquebase.ai/institutions/saimofei"}